KalVista Pharmaceuticals (KALV) Debt Ratio (2014 - 2016)
KalVista Pharmaceuticals (KALV) reported Debt Ratio of 0.09 for Q1 2016, down 83.88% on a YoY basis from 0.58 in Q2 2015, and up 15.37% sequentially from 0.08 in Q4 2015.
KalVista Pharmaceuticals (KALV) Debt Ratio (2014 - 2016) Analysis & Trends
KalVista Pharmaceuticals (KALV) has 3 years of Debt Ratio data on file, last reported at 0.09 in Q1 2016.
- For the quarter ending Q1 2016, Debt Ratio fell 83.88% year-over-year to 0.09; the trailing twelve-month figure through Mar 2016 stood at 0.09 (down 83.88% YoY), and the FY2016 full-year result was 0.01, changed N/A from the prior year.
- Debt Ratio advanced to 0.09 in Q1 2016, from 0.08 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.67 in Q4 2014 to a low of 0.07 in Q2 2015.
- A 3-year average of 0.26 and a median of 0.09 in 2015 frame the typical range for Debt Ratio.
- Across the five-year window, Debt Ratio slumped 87.84% in 2015 and plunged 83.88% in 2016, its largest moves.
- Tracing KALV's Debt Ratio over 3 years: stood at 0.67 in 2014, then tumbled by 87.84% to 0.08 in 2015, then rose by 15.37% to 0.09 in 2016.
- Business Quant data shows KALV's Debt Ratio at 0.09 in Q1 2016, 0.08 in Q4 2015, and 0.07 in Q3 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 0.09 |
| Dec 31, 2015 | 0.08 |
| Sep 30, 2015 | 0.07 |
| Jun 30, 2015 | 0.07 |
| Mar 31, 2015 | 0.58 |
| Dec 31, 2014 | 0.67 |